Exonate Ltd., a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases, today announced plans to initiate a Phase IIb clinical ...

More than 170 people were screened for a condition known as diabetic eye disease through a free programme offered across the ...

Researchers at Edith Cowan University (ECU) have developed a cutting-edge Artificial Intelligence (AI) system that could ...

In this research topic we would like to address the question of what improvements are needed in the treatment of posterior eye disease. These improvements ...

In recent times, the computer vision (CV) then Internet of Things (IoT) technologies have proven their worth across a range of applications, with a notable focus on healthcare. IoT-driven healthcare ...

Diabetic retinopathy is the leading cause of vision loss in working-age adults worldwide, yet under-resourced regions lack ophthalmologists. Current state-of-the-art deeplearning systems struggle at ...

Doctors in India are constantly raising alarms over the rise in cases of vision loss among those battling type 2 ...

(HealthDay News) — An artificial intelligence (AI) model integrated into a retina tracker for diabetic retinopathy can achieve high accuracy while being resource-efficient, according to a study ...

Microaneurysm (MA) turnover increases with the progression of nonproliferative diabetic retinopathy (NPDR) and is correlated with presence of intraretinal microvascular abnormalities (IRMAs), ...